H-Index
38
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
call: +1.631.629.4327
Mon-Fri 10 am - 2 pm EST

Logo

MSMbanner
Medical Science Monitor Basic Research

AmJCaseRep
MedSciTechnol

eISSN: 2329-0358

Get your full text copy in PDF

The assessment of PFA-100 test for the estimation of blood loss in renal transplantation operation

Zeki Ertug, Umit Celik, Necmiye Hadimioglu, Ayhan Dinckan, Sebahat Ozdem

Ann Transplant 2010; 15(1): 46-52

ID: 880568


Background:    Platelate dysfunction is well known factor that may play a role in bleeding diathesis in uremia In recent years, Platelet Function Assay 100 (PFA-100) was introduced to measure platelet function. The purpose of this study was to determine whether an abnormal PFA-100 is an accurate predictor of bleeding in dialysis patients undergoing renal transplantation (RTx).
Material/Methods:    We included 98 dialysis patients undergoing RTx operation. PFA-100 test measuring collagen/epinephrine (Col/EPI) and collagen/adenosine 5'-diphosphate (Col/ADP) closure was performed in each patients after induction of anesthesia. We compared intraoperative blood loss measured by gravimetric method during RTx operation method between patients with normal Col/EPI and Col/ADP closure times (group 1, n= 51) and with prolonged Col/EPI and Col/ADP closure times (group 2, n=47).
Results:    Intraoperative blood loss calculated by gravimetric method was 273±50 ml in the group 1 and 303±109 ml in the group 2 (p>0.05). Blood loss in gross formula was 356±87 ml in the group 1 and 450±99 ml in group 2 (p>0.05).
Conclusions:    Assessment of platelet function with preoperative measurement of PFA-100 in RTx patients is not an effective method for estimating the risk of blood loss in the intraoperative and postoperative periods.

Keywords: renal transplantation, PFA-100

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree